Financials National Research Corporation

Equities

NRC

US6373722023

Business Support Services

Market Closed - Nasdaq 21:00:00 26/04/2024 BST 5-day change 1st Jan Change
33.81 USD +0.65% Intraday chart for National Research Corporation -0.65% -14.53%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 941.4 1,638 1,080 1,056 920.5 971
Enterprise Value (EV) 1 967.2 1,661 1,078 1,030 918.9 1,003
P/E ratio 34.5 x 52.3 x 29.5 x 28.4 x 29.4 x 31.6 x
Yield 1.65% 1.18% 0.49% 1.16% 2.25% 1.21%
Capitalization / Revenue 7.87 x 12.8 x 8.1 x 7.14 x 6.07 x 6.54 x
EV / Revenue 8.08 x 13 x 8.09 x 6.96 x 6.06 x 6.75 x
EV / EBITDA 23.7 x 34.2 x 21.7 x 18.2 x 17.7 x 21.8 x
EV / FCF 26.6 x 96.2 x 56.7 x 25.5 x 49.4 x 59.6 x
FCF Yield 3.75% 1.04% 1.76% 3.92% 2.02% 1.68%
Price to Book 49.4 x 49.8 x 16.9 x 11.9 x 12.7 x 19.6 x
Nbr of stocks (in thousands) 24,684 24,836 25,260 25,436 24,679 24,546
Reference price 2 38.14 65.94 42.75 41.52 37.30 39.56
Announcement Date 08/03/19 06/03/20 05/03/21 04/03/22 03/03/23 27/02/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 119.7 128 133.3 148 151.6 148.6
EBITDA 1 40.79 48.57 49.65 56.76 51.83 45.98
EBIT 1 35.33 43.04 42.86 50.71 46.56 40.09
Operating Margin 29.52% 33.63% 32.16% 34.28% 30.72% 26.98%
Earnings before Tax (EBT) 1 34.71 40.52 41.47 48.62 42.82 39.96
Net income 1 30.05 32.41 37.26 37.47 31.8 30.97
Net margin 25.1% 25.32% 27.96% 25.32% 20.98% 20.84%
EPS 2 1.106 1.260 1.450 1.460 1.270 1.250
Free Cash Flow 1 36.31 17.26 19.02 40.37 18.59 16.85
FCF margin 30.34% 13.49% 14.27% 27.29% 12.26% 11.34%
FCF Conversion (EBITDA) 89.02% 35.54% 38.31% 71.12% 35.86% 36.63%
FCF Conversion (Net income) 120.85% 53.27% 51.05% 107.75% 58.45% 54.39%
Dividend per Share 2 0.6300 0.7800 0.2100 0.4800 0.8400 0.4800
Announcement Date 08/03/19 06/03/20 05/03/21 04/03/22 03/03/23 27/02/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 25.7 23.1 - - - 32.3
Net Cash position 1 - - 1.45 25.7 1.64 -
Leverage (Debt/EBITDA) 0.6309 x 0.4757 x - - - 0.7025 x
Free Cash Flow 1 36.3 17.3 19 40.4 18.6 16.8
ROE (net income / shareholders' equity) 55.1% 125% 76.7% 50.1% 40.4% 51.2%
ROA (Net income/ Total Assets) 18.8% 24.6% 21.9% 21.8% 20.2% 19.8%
Assets 1 160.1 131.8 169.8 172 157.4 156.3
Book Value Per Share 2 0.7700 1.320 2.530 3.480 2.930 2.020
Cash Flow per Share 2 0.5300 0.5400 1.370 2.210 1.020 0.2700
Capex 1 5.97 4.66 3.98 5.51 9.84 15.8
Capex / Sales 4.99% 3.64% 2.99% 3.73% 6.49% 10.62%
Announcement Date 08/03/19 06/03/20 05/03/21 04/03/22 03/03/23 27/02/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. NRC Stock
  4. Financials National Research Corporation